Case number 1:23-cv-00486
Astellas Pharma Inc. et al v. Ascent Pharmaceuticals, Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 1, 2024 | 67 | NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Defendant Ascent's First Interrogatories (Nos. 1-5), and (2) Plaintiffs' Objections and Responses to Defendant Ascent's First Request for Production of Documents and Things (Nos. 1-19) filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Joyce, Alexandra) (Entered: 07/01/2024) (2) |
| Jun 24, 2024 | 66 | DECLARATION re 65 Statement of Vincent Li, Esq. by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Exhibit 22-25)(Silver, Daniel) (Entered: 06/24/2024) (0) |
| Jun 24, 2024 | 65 | STATEMENT Astellas' Supplemental Claim Construction Brief by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Silver, Daniel) (Main Document 65 replaced on 6/25/2024) (mpb). (Entered: 06/24/2024) (14) |
| Jun 24, 2024 | 64 | DECLARATION re 63 Statement // executed by Sri K. Sankaran by Ascent Pharmaceuticals, Inc.. (Hitch, Cortlan) (Entered: 06/24/2024) (30) |
| Jun 24, 2024 | 63 | STATEMENT - Ascent's Supplemental Claim Construction Brief by Ascent Pharmaceuticals, Inc.. (Hitch, Cortlan) (Entered: 06/24/2024) (18) |
| Jun 21, 2024 | 62 | NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to MSN Defendants' First Set of Requests for Production of Documents and Things (Nos 1-18) and (2) Plaintiffs' Objections and Responses to Defendants' Second Set of Interrogatories (Nos. 2-6) filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Silver, Daniel) (Entered: 06/21/2024) (2) |
| Jun 7, 2024 | 61 | Joint Letter to The Honorable Christopher J. Burke from The Parties regarding Interim Joint Status Report. (Joyce, Alexandra) (Entered: 06/07/2024) (3) |
| Jun 5, 2024 | 60 | ORDER granting D.I. 59 Joint MOTION for Exemption of Persons from the May 17, 2024 Standing Order on Personal Devices. Signed by Judge Joseph F. Bataillon on 6/5/2024. (apk) (Entered: 06/05/2024) (2) |
| Jun 4, 2024 | 59 | Joint MOTION for Exemption of Persons from the May 17, 2024 Standing Order on Personal Devices - filed by Ascent Pharmaceuticals, Inc.(Dorsney, Kenneth) Modified on 6/4/2024(smg). (Entered: 06/04/2024) (3) |
| May 31, 2024 | 58 | NOTICE OF SERVICE of (1) Defendant Ascent Pharmaceuticals Inc.'s First Set of Requests for Production (Nos. 1-19) and; (2) Defendant Ascent Pharmaceuticals Inc.'s First Set of Interrogatories (Nos. 1-5) filed by Ascent Pharmaceuticals, Inc..(Dorsney, Kenneth) (Entered: 05/31/2024) (2) |
| May 30, 2024 | 57 | ORAL ORDER: The Markman hearing scheduled for 6/13/2024 at 11:00 AM, will be held in Courtroom 2A at the J. Caleb Boggs Federal Building, 844 N. King Street, Wilmington, Delaware, before Judge Joseph F. Bataillon. Signed by Judge Joseph F. Bataillon on 05/30/2024. Associated Cases: 1:23-cv-00486-JFB-CJB, 1:23-cv-00689-JFB-CJB (AEV) (Entered: 05/30/2024) (0) |
| May 24, 2024 | 56 | Pro Hac Vice Fee - Credit Card Payment received for Devan Padmanabhan. ( re 54 MOTION for Pro Hac Vice Appearance of Attorney Devan Padmanabhan and Sri K. Sankaran )( Payment of $ 50, receipt number ADEDC-4415160).(Dorsney, Kenneth) (Entered: 05/24/2024) (0) |
| May 24, 2024 | 55 | Pro Hac Vice Fee - Credit Card Payment received for Sri K. Sankaran. ( re 54 MOTION for Pro Hac Vice Appearance of Attorney Devan Padmanabhan and Sri K. Sankaran )( Payment of $ 50, receipt number ADEDC-4414977).(Dorsney, Kenneth) (Entered: 05/24/2024) (0) |
| May 24, 2024 | 54 | MOTION for Pro Hac Vice Appearance of Attorney Devan Padmanabhan and Sri K. Sankaran - filed by Ascent Pharmaceuticals, Inc.. Motions referred to Christopher J. Burke.(Dorsney, Kenneth) (Entered: 05/24/2024) (4) |
| May 22, 2024 | 53 | NOTICE OF SERVICE of (1) Defendants MSN Laboratories Private Ltd. and MSN Pharmaceuticals Inc.'s Second Set of Interrogatories to Plaintiffs (Nos. 2-6) and; (2) Defendants MSN Laboratories Private Ltd. and MSN Pharmaceuticals Inc.'s First Set of Requests for Production to Plaintiffs (Nos. 1-18) filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc..(Dorsney, Kenneth) (Entered: 05/22/2024) (2) |
| May 9, 2024 | 52 | REDACTED VERSION of 47 Appendix, by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 05/09/2024) (22) |
| May 9, 2024 | 51 | REDACTED VERSION of 45 Joint Claim Construction Brief by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 05/09/2024) (30) |
| May 2, 2024 | 50 | MOTION for Claim Construction - filed by Ascent Pharmaceuticals, Inc. (Dorsney, Kenneth) Modified on 5/2/2024 (smg). (Entered: 05/02/2024) (1) |
| May 2, 2024 | 49 | MOTION for Claim Construction re 45 Joint Claim Construction Brief - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Proposed Order, # 2 Rule 7.1.1 Certification)(Joyce, Alexandra) Modified on 5/2/2024 (smg). (Entered: 05/02/2024) (0) |
| May 2, 2024 | 48 | Joint Letter to The Honorable Joseph F. Bataillon from Alexandra M. Joyce and Kenneth L. Dorsney regarding Markman Hearing. (Joyce, Alexandra) (Entered: 05/02/2024) (1) |
| May 2, 2024 | 47 | [SEALED] Joint APPENDIX re 45 Joint Claim Construction Brief SEALED Exhibit 4 by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Exhibit 4, # 2 Certificate of Service)(Joyce, Alexandra) (Entered: 05/02/2024) (0) |
| May 2, 2024 | 46 | Joint APPENDIX re 45 Joint Claim Construction Brief by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Exhibits 1-3, # 2 Exhibits 5-21)(Joyce, Alexandra) (Entered: 05/02/2024) (0) |
| May 2, 2024 | 45 | [SEALED] JOINT CLAIM CONSTRUCTION BRIEF filed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc.. (Attachments: # 1 Certificate of Service)(Joyce, Alexandra) (Entered: 05/02/2024) (0) |
| Apr 25, 2024 | 44 | NOTICE OF SERVICE of Defendant Ascent Pharmaceuticals Inc.'s Sur-Reply Claim Construction Brief filed by Ascent Pharmaceuticals, Inc..(Dorsney, Kenneth) (Entered: 04/25/2024) (2) |
| Apr 9, 2024 | 43 | NOTICE OF SERVICE of Astellas' Reply Claim Construction Brief filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Joyce, Alexandra) (Entered: 04/09/2024) (2) |
| Mar 22, 2024 | 42 | NOTICE OF SERVICE of Defendant Ascent Pharmaceuticals Inc.'s Responsive Claim Construction Brief filed by Ascent Pharmaceuticals, Inc..(Hitch, Cortlan) (Entered: 03/22/2024) (2) |
| Feb 23, 2024 | 41 | NOTICE OF SERVICE of Astellas' Opening Claim Construction Brief filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Joyce, Alexandra) (Entered: 02/23/2024) (2) |
| Feb 9, 2024 | 40 | Joint APPENDIX re 39 Claim Construction Chart by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B-Q)(Joyce, Alexandra) (Entered: 02/09/2024) (0) |
| Feb 9, 2024 | 39 | CLAIM Construction Chart by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 02/09/2024) (7) |
| Feb 8, 2024 | 38 | NOTICE OF SERVICE of Defendant Ascent Pharmaceuticals Inc.'s Responses and Objections to Plaintiffs' First Set of Interrogatories (Nos. 1-18) filed by Ascent Pharmaceuticals, Inc..(Dorsney, Kenneth) (Entered: 02/08/2024) (2) |
| Feb 1, 2024 | 37 | STIPULATION TO EXTEND TIME to submit a Joint Claim Construction Chart to February 9, 2024 - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Silver, Daniel) (Entered: 02/01/2024) (2) |
| Jan 26, 2024 | 36 | NOTICE OF SERVICE of Defendant Ascent Pharmaceuticals, Inc.'s Initial Invalidity Contentions filed by Ascent Pharmaceuticals, Inc..(Dorsney, Kenneth) (Entered: 01/26/2024) (2) |
| Jan 24, 2024 | 35 | NOTICE requesting Clerk to remove Rodney Swartz as co-counsel.. (Joyce, Alexandra) (Entered: 01/24/2024) (2) |
| Jan 22, 2024 | 34 | STIPULATION TO EXTEND TIME the Deadline for the Parties to Submit the Joint Claim Construction Chart to February 2, 2024 - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 01/22/2024) (2) |
| Jan 10, 2024 | 33 | NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories to Ascent (Nos. 1-18) filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Joyce, Alexandra) (Entered: 01/10/2024) (2) |
| Jan 8, 2024 | 32 | NOTICE OF SERVICE of Defendant Ascent Pharmaceuticals Inc.'s Claim Terms and Proposed Constructions filed by Ascent Pharmaceuticals, Inc..(Hitch, Cortlan) (Entered: 01/08/2024) (2) |
| Jan 3, 2024 | 31 | NOTICE OF SERVICE of Defendant Ascent Pharmaceuticals Inc.'s response to Plaintiffs' First Set of Requests for Production (Nos. 1-25) filed by Ascent Pharmaceuticals, Inc..(Dorsney, Kenneth) (Entered: 01/03/2024) (2) |
| Dec 27, 2023 | 30 | NOTICE OF SERVICE of Plaintiffs' Initial Infringement Charts filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Joyce, Alexandra) (Entered: 12/27/2023) (2) |
| Dec 7, 2023 | 29 | Joint Letter to The Honorable Christopher J. Burke from the Parties regarding Interim Joint Status Report. (Joyce, Alexandra) (Entered: 12/07/2023) (2) |
| Dec 4, 2023 | 28 | NOTICE OF SERVICE of Plaintiffs' First Set of Requests to Defendant for the Production of Documents and Things (Nos. 1-25) filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Joyce, Alexandra) (Entered: 12/04/2023) (2) |
| Nov 28, 2023 | 27 | NOTICE OF SERVICE of Defendant Ascent Pharmaceuticals Inc.'s Paragraph 4(b) Disclosures filed by Ascent Pharmaceuticals, Inc..(Dorsney, Kenneth) (Entered: 11/28/2023) (2) |
| Oct 26, 2023 | 26 | NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Identifying Defendant's Accused Products and Plaintiffs' Asserted Patent filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Joyce, Alexandra) (Entered: 10/26/2023) (2) |
| Oct 10, 2023 | 25 | NOTICE OF SERVICE of (1) Plaintiff's Disclosures Pursuant to Paragraph 3 of the Court's Default Standard for Discovery and (2) Plaintiff's Rule 26(a)(1) Initial Disclosures for Litigation Involving U.S. Patent No. 10,842,780 filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Joyce, Alexandra) (Entered: 10/10/2023) (2) |
| Oct 10, 2023 | 24 | NOTICE OF SERVICE of (1) Defendant Ascent Pharmaceuticals Inc.'s Rule 26(a)(1) Initial Disclosures; and (2) Defendant Ascent Pharmaceuticals Inc.'s Paragraph 3 Disclosures filed by Ascent Pharmaceuticals, Inc..(Dorsney, Kenneth) (Entered: 10/10/2023) (2) |
| Oct 5, 2023 | 23 | PROTECTIVE ORDER. Signed by Judge Christopher J. Burke on 10/4/2023. (mlc) (Entered: 10/05/2023) (30) |
| Oct 4, 2023 | 22 | PROPOSED ORDER Stipulated Protective Order by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 10/04/2023) (30) |
| Oct 2, 2023 | 21 | STIPULATION TO EXTEND TIME Proposed Protective Order to October 4, 2023 - filed by Ascent Pharmaceuticals, Inc.. (Dorsney, Kenneth) (Entered: 10/02/2023) (2) |
| Sep 27, 2023 | 20 | ORDER: Defendant is granted leave to bring one dispositive motion on the grounds of issue preclusion (collateral estoppel) under Fed R. Civ. P. 12(c) or 56, based on this Court's ruling in Astellas Pharma Inc. v. Sandoz Inc., 1:20-cv-01589-JFB-CJB litigation that claims 5, 20, and 25 of patent-in-suit are invalid under 35 U.S.C. § 101 as directed to unpatentable subject matter. Defendant shall file its motion within 30 days after the Federal Circuit issues its ruling in the appeal in Astellas Pharma Inc. v. Sandoz Inc. Signed by Judge Joseph F. Bataillon on 9/27/2023. (apk) (Entered: 09/27/2023) (2) |
| Sep 26, 2023 | 19 | SCHEDULING ORDER: Joinder of Parties due by 8/1/2024, Amended Pleadings due by 8/1/2024, Discovery due by 10/8/2024, Opening Expert Reports due by 11/22/2024, Rebuttal Expert Reports due by 12/23/2024, Reply Expert Reports due by 1/23/2025, Status Report due by 12/8/2023, Claim Construction Opening Brief due by 2/23/2024, Claim Construction Answering Brief due by 3/22/2024, Claim Construction Reply Brief due by 4/9/2024, Claim Construction Surreply Brief due by 4/25/2024, Joint Claim Construction Brief due by 5/2/2024, A Markman Hearing is set for 6/13/2024 at 11:00 AM before Judge Joseph F. Bataillon, A Pretrial Conference is set for 6/20/2025 at 11:00 AM in Courtroom 2A before Judge Christopher J. Burke, A 5 -day Bench Trial is set for 7/14/2025 at 09:30 AM before Judge Joseph F. Bataillon. IT IS FURTHER ORDERED that with regard to the parties' dispute regarding whether Defendant should be granted leave to file an early summary judgment motion, the Court conferred with the District Judge, who indicated that any motion for leave to file an early summary judgment motion should be made separately to his attention. The District Judge will resolve any such motion in the future. For now, the Court has stricken Defendant's proposal regarding this subject from the Scheduling Order entered today. See Order for further details and deadlines.Signed by Judge Christopher J. Burke on 9/26/2023. (dlb) (Entered: 09/26/2023) (15) |
| Sep 15, 2023 | 18 | Letter to The Honorable Christopher J. Burke from Alexandra M. Joyce, Esq. and Cortlan S. Hitch, Esq. regarding [Proposed] Scheduling Order and Case Management Checklist. (Attachments: # 1 Case Management Checklist, # 2 Patent Case Scheduling Order)(Joyce, Alexandra) (Entered: 09/15/2023) (0) |
| Sep 8, 2023 | 17 | STIPULATION TO EXTEND TIME for the parties to file the Proposed Scheduling Order, Case Management Checklist and Letter to September 15, 2023 - filed by Ascent Pharmaceuticals, Inc.. (Dorsney, Kenneth) (Entered: 09/08/2023) (2) |
| Aug 29, 2023 | 16 | NOTICE requesting Clerk to remove Nitya Anand as co-counsel.. (Joyce, Alexandra) (Entered: 08/29/2023) (2) |
| Aug 25, 2023 | 15 | NOTICE of Change of Address by Kenneth Laurence Dorsney (Dorsney, Kenneth) (Entered: 08/25/2023) (2) |
| Aug 9, 2023 | 14 | ORAL ORDER: IT IS HEREBY ORDERED that the parties shall meet and confer and discuss, in person and/or by telephone, each of the matters listed on Judge Burke's Case Management Checklist (Checklist). Within thirty (30) days from the date of this Order, the parties shall jointly file the following: (i) a copy of the Checklist, indicating the names of Lead Counsel and Delaware Counsel for each party; (ii) a proposed Scheduling Order, which is consistent with Judge Burke/s "Rule 16 Scheduling Order - Patent" (and with additional changes made to accommodate the fact that this is an ANDA litigation matter); and (iii) a letter, not to exceed three pages, that contains the following: (a) a description of what this case is about; (b) the parties' positions regarding any disputes in the proposed Scheduling Order, and (c) a list of the three most significant topics (other than Scheduling Order disputes) discussed during the parties review of the Checklist items, along with a brief description as to what was discussed as to those topics. Thereafter, the Court may schedule a Case Management Conference/Rule 16 Scheduling Conference to be held with Judge Burke. The Checklist and Scheduling Order can be found on Judge Burke's portion of the District Court's website. Ordered by Judge Christopher J. Burke on 8/9/2023. (dlb) (Entered: 08/09/2023) (0) |
| Jul 26, 2023 | 13 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Ascent Pharmaceuticals, Inc.. (Dorsney, Kenneth) (Entered: 07/26/2023) (1) |
| Jul 26, 2023 | 12 | ANSWER to 1 Complaint, by Ascent Pharmaceuticals, Inc..(Dorsney, Kenneth) (Entered: 07/26/2023) (17) |
| Jun 23, 2023 | N/A | SO ORDERED D.I. 11 STIPULATION TO EXTEND TIME respond to complaint to July 26, 2023 filed by Ascent Pharmaceuticals, Inc., Set/Reset Answer Deadlines: Ascent Pharmaceuticals, Inc. answer due 7/26/2023. Ordered by Judge Christopher J. Burke on 6/23/2023. (mlc) (Entered: 06/23/2023) (0) |
| Jun 22, 2023 | 11 | STIPULATION TO EXTEND TIME respond to complaint to July 26, 2023 - filed by Ascent Pharmaceuticals, Inc.. (Dorsney, Kenneth) (Entered: 06/22/2023) (2) |
| May 26, 2023 | N/A | Pro Hac Vice Attorney Jayita Guhaniyogi for Astellas Ireland Co., Ltd. Astellas Pharma Global Development, Inc., Astellas Pharma Inc.,J Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., and for Astellas Pharma Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:23-cv-00022-JFB-CJB, 1:23-cv-00486-JFB-CJB(smg) (Entered: 05/26/2023) (0) |
| May 26, 2023 | N/A | Pro Hac Vice Attorney Nitya Anand for Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., and for Astellas Pharma Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:23-cv-00022-JFB-CJB, 1:23-cv-00486-JFB-CJB(smg) (Entered: 05/26/2023) (0) |
| May 23, 2023 | N/A | Pro Hac Vice Attorney Connor S. Romm for Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., and Astellas Pharma Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:23-cv-00022-JFB-CJB, 1:23-cv-00486-JFB-CJB(mkr) (Entered: 05/23/2023) (0) |
| May 23, 2023 | N/A | Pro Hac Vice Attorney Simon D. Roberts and Rodney D. Swartz, II for Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., and Astellas Pharma Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:23-cv-00022-JFB-CJB, 1:23-cv-00486-JFB-CJB(mpb) (Entered: 05/23/2023) (0) |
| May 23, 2023 | N/A | SO ORDERED D.I. 8 Stipulation filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc., Reset Answer Deadline: Ascent Pharmaceuticals, Inc. answer due 6/26/2023. Ordered by Judge Christopher J. Burke on 5/23/2023. (dlb) (Entered: 05/23/2023) (0) |
| May 23, 2023 | N/A | SO ORDERED D.I. 9 MOTION for Pro Hac Vice Appearance of Attorney Simon D. Roberts, Jason A. Leonard, Jayita Guhaniyogi, Nitya Anand, Vincent Li, Connor S. Romm, and Rodney Swartz filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc. Ordered by Judge Christopher J. Burke on 5/23/2023. (dlb) (Entered: 05/23/2023) (0) |
| May 23, 2023 | N/A | Remark: The parties should follow the Court's Standing Order Regarding Courtesy Copies, a copy of which is found on Judge Burke's portion of the District Court's webpage: https://www.ded.uscourts.gov/sites/ded/files/CJBCC2022.pdf (dlb) (Entered: 05/23/2023) (0) |
| May 23, 2023 | N/A | REMARK: The parties should be aware that the Court encourages the participation of newer attorneys in courtroom proceedings and at oral argument. Please see the Court's Standing Order Regarding Courtroom Opportunities for Newer Attorneys, a link to which is provided here for the parties' convenience:http://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrder2017.pdf (dlb) (Entered: 05/23/2023) (0) |
| May 22, 2023 | 10 | ORAL ORDER: Pursuant to the filing of this case, the Court issues the following order: Magistrate Judge Christopher J. Burke shall issue a scheduling order when appropriate. Magistrate Judge Burke shall handle all nondispositive matters on all issues, except for Daubert motions, Markman hearings, and pretrial motions in limine. The parties have the right to file an appeal of the magistrate judge's order, and the same shall be decided by the undersigned. The magistrate judge shall likewise handle all discovery matters, scheduling, and pretrial conferences. If the parties believe the magistrate judge has a conflict of interest with this case, the parties shall so notify the Court. IT IS SO ORDERED. Signed by Judge Joseph F. Bataillon on 05/22/2023. (AEV) (Entered: 05/22/2023) (0) |
| May 17, 2023 | 9 | MOTION for Pro Hac Vice Appearance of Attorney Simon D. Roberts, Jason A. Leonard, Jayita Guhaniyogi, Nitya Anand, Vincent Li, Connor S. Romm, and Rodney Swartz - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Certifications for Simon D. Roberts, Jason A. Leonard, Jayita Guhaniyogi, Nitya Anand, Vincent Li, Connor S. Romm, and Rodney Swartz)(Joyce, Alexandra) (Entered: 05/17/2023) (Certifications for Simon D. Roberts, Jason A. Leonard, Jayita Guhaniyogi, Nitya) (7) |
| May 17, 2023 | 9 | MOTION for Pro Hac Vice Appearance of Attorney Simon D. Roberts, Jason A. Leonard, Jayita Guhaniyogi, Nitya Anand, Vincent Li, Connor S. Romm, and Rodney Swartz - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Certifications for Simon D. Roberts, Jason A. Leonard, Jayita Guhaniyogi, Nitya Anand, Vincent Li, Connor S. Romm, and Rodney Swartz)(Joyce, Alexandra) (Entered: 05/17/2023) (Main Document) (2) |
| May 16, 2023 | 8 | STIPULATION regarding Venue and Personal Jurisdiction and to Extend Time for Response to Complaint by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 05/16/2023) (3) |
| May 10, 2023 | N/A | Case Assigned to Judge Joseph F. Bataillon of the United States District Court for the District of Nebraska, due to related cases. Please include the initials of the Judge (JFB) after the case number on all documents filed. (rjb) (Entered: 05/10/2023) (0) |
| May 8, 2023 | 7 | DECLARATION of Service on Ascent Pharmaceuticals, Inc. by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Exhibit A-B)(Joyce, Alexandra) (Entered: 05/08/2023) (Exhibit A-B) (8) |
| May 8, 2023 | 7 | DECLARATION of Service on Ascent Pharmaceuticals, Inc. by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Exhibit A-B)(Joyce, Alexandra) (Entered: 05/08/2023) (Main Document) (2) |
| May 3, 2023 | 1 | COMPLAINT for ANDA/PATENT INFRINGEMENT filed against Ascent Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4127096.) - filed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet) (vfm) (Entered: 05/03/2023) (Civil Cover Sheet) (3) |
| May 3, 2023 | 1 | COMPLAINT for ANDA/PATENT INFRINGEMENT filed against Ascent Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4127096.) - filed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet) (vfm) (Entered: 05/03/2023) (Exhibit A) (19) |
| May 3, 2023 | 6 | Summons Issued as to Ascent Pharmaceuticals, Inc. on 5/3/2023. (vfm) (Entered: 05/03/2023) (2) |
| May 3, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Astellas US Holding, Inc. for Astellas Pharma Global Development, Inc.; Corporate Parent Astellas B.V. for Astellas Ireland Co., Ltd., Astellas Pharma Inc. filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (vfm) (Entered: 05/03/2023) (2) |
| May 3, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,842,780. (vfm) (Entered: 05/03/2023) (1) |
| May 3, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 03/22/2023. Date of Expiration of Patent: 09/28/2029.Thirty Month Stay Deadline: 9/22/2025. (vfm) (Entered: 05/03/2023) (2) |
| May 3, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm) (Entered: 05/03/2023) (3) |
| May 3, 2023 | 1 | COMPLAINT for ANDA/PATENT INFRINGEMENT filed against Ascent Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4127096.) - filed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet) (vfm) (Entered: 05/03/2023) (Main Document) (13) |
